Early symptoms in <i>RPGR</i> -associated retinal degeneration: can we shorten time to diagnosis in the gene therapy era?
This study identified characteristics to facilitate earlier diagnosis of <i>RPGR-</i>RD, potentially shortening time to treatment and preventing further vision loss.
Authors
- Thiran Jayasundera (ORCID: https://orcid.org/0000-0003-4895-4818)
- Chris Andrews (ORCID: https://orcid.org/0000-0001-5130-6374)
- Dejan Milentijevic (ORCID: https://orcid.org/0000-0003-2159-0049)
- Kari Branham (ORCID: https://orcid.org/0000-0002-2492-254X)
- Divya Narayanan
Institutions
- Johnson & Johnson (United States) (US)
- University of Michigan (US)
- Johnson & Johnson (Israel) (IL)
Publication Details
- Journal
- Ophthalmic Genetics
- Published
- 2025-07-13
- DOI
- https://doi.org/10.1080/13816810.2025.2525469
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00